Orthofix Medical (OFIX) Return on Sales (2010 - 2026)

Orthofix Medical has disclosed Return on Sales across 17 years of filings, most recently posting 0.0% for Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales retreated to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q4 2023 and troughed at 0.0% in Q1 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2023 — Return on Sales gained 1 bps — and 2024, when it slipped 1 bps.
• Tracing OFIX's Return on Sales over 5 years: stood at 0.0% in 2022, then surged by 955 bps to 0.01% in 2023, then sank by 120 bps to 0.0% in 2024, then surged by 333 bps to 0.0% in 2025, then plunged by 127 bps to 0.0% in 2026.
• Business Quant data shows OFIX's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.